Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Factor |
Reference |
Absorption |
55.0 |
% |
50-60 |
% |
Tablet, PO, oral; fasting; |
|
DRUGBANK |
Bioavailability |
52.0 |
% |
52±5(40-55) |
% |
PO, oral; |
|
The Pharmacological Basis of Therapeutics |
C Max |
1600.0 |
ng/ml |
1.6±0.2 |
mcg/ml |
Tablet, PO, oral; |
|
The Pharmacological Basis of Therapeutics |
C Max |
2050.0 |
ng/ml |
1.0-3.1 |
mcg/ml |
PO, oral; |
|
The Pharmacological Basis of Therapeutics |
Css |
1000.0 |
ng/ml |
<1 |
ug/ml |
PO, oral; |
|
DRUGBANK |
T Max |
7.0 |
h |
7(4-8) |
h |
PO, oral; extended release formulation; |
|
DRUGBANK |
T Max |
1.9 |
h |
1.9±0.4 |
h |
Tablet, PO, oral; |
|
The Pharmacological Basis of Therapeutics |
T Max |
2.5 |
h |
1.5-3.5 |
h |
PO, oral; |
|
The Pharmacological Basis of Therapeutics |
Tss |
36.0 |
h |
24-48 |
h |
PO, oral; |
|
DRUGBANK |
Metabolic |
0 |
% |
0 |
% |
|
|
DRUGBANK |
Clearance |
0.49 |
L/h/kg |
6.3-10.1 |
ml/min/kg |
|
Elderly ↓ ;mild renal function ↓ ;moderate renal function ↓ ;severe renal function ↓ ; |
The Pharmacological Basis of Therapeutics |
Clearance |
0.44 |
L/h/kg |
7.4 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
654.0 |
L |
654±358 |
L |
Apparent volume of distribution; PO, oral; |
|
DRUGBANK |
Volume of Distribution |
2.3 |
L/kg |
0.9-3.94 |
L/kg |
|
|
The Pharmacological Basis of Therapeutics |
Volume of Distribution |
0.64 |
L/kg |
0.64 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Half-life |
6.2 |
h |
6.2 |
h |
|
|
DRUGBANK |
Half-life |
17.6 |
h |
17.6 |
h |
elimination half-life; |
|
DRUGBANK |
Half-life |
1.7 |
h |
1.74±0.20(1.5-4.5) |
h |
|
mild renal function ↑ ;moderate renal function ↑ ;severe renal function ↑ ;Age ↑ ; |
The Pharmacological Basis of Therapeutics |
Half-life |
1.7 |
h |
1.7 |
h |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Toxicity LD50 |
1000.0 |
mg/kg |
1.0 |
g/kg |
PO, oral; Rattus, Rat; |
|
DRUGBANK |
Toxicity LD50 |
500.0 |
mg/kg |
500.0 |
mg/kg |
Intraperitoneal, IP; Rattus, Rat; |
|
DRUGBANK |
Toxicity LD50 |
300.0 |
mg/kg |
300.0 |
mg/kg |
subcutaneous injection, SC; Rattus, Rat; |
|
DRUGBANK |
Toxicity LD50 |
1450.0 |
mg/kg |
1450.0 |
mg/kg |
PO, oral; mouse; |
|
DRUGBANK |
Toxicity LD50 |
420.0 |
mg/kg |
420.0 |
mg/kg |
Intraperitoneal, IP; mouse; |
|
DRUGBANK |
Toxicity LD50 |
225.0 |
mg/kg |
225.0 |
mg/kg |
subcutaneous injection, SC; Rattus, Rat; |
|
DRUGBANK |
Toxicity LD50 |
350.0 |
mg/kg |
350.0 |
mg/kg |
PO, oral; rabbit; |
|
T3DB |
Eliminate Route |
90.0 |
% |
~90 |
% |
Urinary excretion; PO, oral; |
|
DRUGBANK |
Eliminate Route |
99.9 |
% |
99.9±0.5 |
% |
Urinary excretion; normal,healthy; human, homo sapiens; Unchanged drug; |
|
The Pharmacological Basis of Therapeutics |
Eliminate Route |
89.5 |
% |
79-100 |
% |
Urinary excretion; normal,healthy; human, homo sapiens; Unchanged drug; |
|
The Pharmacological Basis of Therapeutics |
Protein Binding |
0 |
% |
~0 |
% |
human, homo sapiens; |
|
The Pharmacological Basis of Therapeutics |